Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 108

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 108
---
 2024, we
have financed our operations primarily through private placements and convertible loans. Total invested capital as of June 30, 2024 was
$35.7 million, which included Ordinary Shares, Preferred Shares and warrants to purchase Preferred Shares.

The following table summarizes
our statement of cash flows for the years ended December 31, 2023 and 2022 and the six months periods ended June 30, 2024 and 2023:

| (U.S. dollars in thousands except share and per share data) |     | For the Six Months Ended 
 June 30,                 
 2024                     |      |   |     | 2023 |      |   |     | For the Years Ended 
 December 31,        
 2023                |        |   |     | 2022 |          |   |
|:------------------------------------------------------------|:----|:-------------------------|-----:|:--|:----|:-----|:-----|:--|:----|:--------------------|-------:|:--|:----|:-----|:---------|:--|
| Net cash used in operating activities                       |     | $                        |    6 |   |     |      | (755 | ) |     | $                   | (1,220 | ) |     |      | ‌(1,504) |   |
| Net cash used in investing activities                       |     |                          |    - |   |     |      | -    |   |     |                     |      - |   |     |      | -        |   |
| Net cash provided by financing activities                   |     |                          | (175 | ) |     |      | -    |   |     |                     |    325 |   |     |      | -        |   |
| (Decrease) Increase in cash and cash equivalents            |     | $                        | (169 | ) |     |      | (755 | ) |     | $                   |   (895 | ) |     |      | (1,504   | ) |

<div align='center'>66</div>

Net cash used in operating activities

Net cash provided by (used in) operating activities

Net cash provided by operating
activities for the six months ended June 30, 2024 was $0.006 million, compared to net cash used in operating activities of $0.75 million
for the six months ended June 30, 2023. This increase